Chisa Kondo

1.0k total citations
45 papers, 487 citations indexed

About

Chisa Kondo is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Chisa Kondo has authored 45 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 32 papers in Hepatology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Chisa Kondo's work include Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (24 papers) and Hepatitis B Virus Studies (13 papers). Chisa Kondo is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (24 papers) and Hepatitis B Virus Studies (13 papers). Chisa Kondo collaborates with scholars based in Japan, United States and South Korea. Chisa Kondo's co-authors include Masanori Atsukawa, Norio Itokawa, Akihito Tsubota, Katsuhiko Iwakiri, Taeang Arai, Tomomi Okubo, Noritomo Shimada, Katsuhisa Nakatsuka, Yūji Yoshida and Choitsu Sakamoto and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Chisa Kondo

43 papers receiving 482 citations

Peers

Countries citing papers authored by Chisa Kondo

Since Specialization

Citations

This map shows the geographic impact of Chisa Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chisa Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chisa Kondo more than expected).

Fields of papers citing papers by Chisa Kondo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chisa Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chisa Kondo. The network helps show where Chisa Kondo may publish in the future.

Co-authorship network of co-authors of Chisa Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Chisa Kondo. A scholar is included among the top collaborators of Chisa Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chisa Kondo. Chisa Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease 2024 ·PLoS ONE ·Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota, Hiroki Ono, (unknown), Yūji Yoshida, Taeang Arai, (unknown), Norio Itokawa, Chisa Kondo, Katsuhiko Iwakiri	1
2	How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis 2023 ·JGH Open ·Masanori Atsukawa, Akihito Tsubota, Yuichi Tamura, (unknown), (unknown), Tomomi Okubo, Korenobu Hayama, Taeang Arai, Norio Itokawa, Yu Taniguchi, (unknown), Chisa Kondo, Katsuhiko Iwakiri	2
3	Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease 2022 ·Scientific Reports ·(unknown), Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hidenori Toyoda, Koichi Takaguchi, Joji Tani, Asahiro Morishita, Atsushi Hiraoka, Shigeru Mikami, Toru Ishikawa, Hironao Okubo, Tsunamasa Watanabe, Tomomi Okubo, Taeang Arai, Korenobu Hayama, Norio Itokawa, Chisa Kondo, Katsuhiko Iwakiri	2
4	Development of interferon-free, direct-acting antivirals treatment for Japanese patients with chronic hepatitis C infection and chronic kidney disease 2021 ·Journal of Nippon Medical School ·Masanori Atsukawa, Chisa Kondo, (unknown), Tomomi Okubo, Taeang Arai, (unknown), Norio Itokawa, Katsuhiko Iwakiri	2
5	Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B 2021 ·Internal Medicine ·Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hidenori Toyoda, Koichi Takaguchi, Atsushi Hiraoka, Tomonori Senoh, (unknown), Yūji Yoshida, Tomomi Okubo, Taeang Arai, Korenobu Hayama, (unknown), Chisa Kondo, Katsuhiko Iwakiri	3
6	Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease 2019 ·PLoS ONE ·Taeang Arai, Masanori Atsukawa, Akihito Tsubota, (unknown), (unknown), Yūji Yoshida, (unknown), Tomomi Okubo, Korenobu Hayama, (unknown), Norio Itokawa, Chisa Kondo, Keiko Kaneko, Chiaki Kawamoto, Tsutomu Hatori, Naoya Emoto, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri	12
7	Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression 2018 ·PLoS ONE ·(unknown), Masanori Atsukawa, Katsuhisa Nakatsuka, Masumi Shimizu, Daishu Miura, Taeang Arai, Hirotomo Harimoto, Chisa Kondo, Keiko Kaneko, Seiji Futagami, Chiaki Kawamoto, Hidemi Takahashi, Katsuhiko Iwakiri	9
8	Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment 2018 ·Hepatology International ·Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, Noritomo Shimada, Hiroshi Abe, Keizo Kato, Korenobu Hayama, Taeang Arai, (unknown), Norio Itokawa, Chisa Kondo, Chiaki Kawamoto, Etsuko Iio, Yasuhito Tanaka, Takashi Kumada, Katsuhiko Iwakiri	16
9	Serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein more reliably distinguishes liver fibrosis stages in non‐alcoholic fatty liver disease than serum Mac‐2 binding protein 2017 ·Hepatology Research ·Masanori Atsukawa, Akihito Tsubota, Tomomi Okubo, Taeang Arai, (unknown), Norio Itokawa, Chisa Kondo, Keizo Kato, Tsutomu Hatori, Hiroshi Hano, Tsunekazu Oikawa, Naoya Emoto, Masanori Abe, Masayoshi Kage, Katsuhiko Iwakiri	14
10	Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C 2017 ·Digestive and Liver Disease ·Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Noritomo Shimada, Hiroshi Abe, Keizo Kato, Tomomi Okubo, Taeang Arai, Norio Itokawa, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri	11
11	Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients 2016 ·World Journal of Gastroenterology ·(unknown), Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Tomomi Okubo, Taeang Arai, Norio Itokawa, Yoshiyuki Narahara, Katsuhiko Iwakiri	12
12	Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study 2015 ·International Journal of Clinical Oncology ·Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Tomomi Okubo, Taeang Arai, (unknown), Chisa Kondo, Katsuhiko Iwakiri	4
13	Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients 2015 ·BMC Infectious Diseases ·Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, (unknown), Hiroshi Abe, Toru Asano, (unknown), Masahiro Araki, Tadashi Ikegami, Chisa Kondo, Norio Itokawa, (unknown), Taeang Arai, Yoko Matsushita, Katsuhisa Nakatsuka, Tomomi Furihata, Yoshimichi Chuganji, Yasushi Matsuzaki, Yoshio Aizawa, Katsuhiko Iwakiri	10
14	Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C 2014 ·Digestive and Liver Disease ·Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hiroshi Abe, Chisa Kondo, Norio Itokawa, (unknown), Katsuhiko Iwakiri, Chiaki Kawamoto, Yoshio Aizawa, Choitsu Sakamoto	14
15	Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C 2014 ·European Journal of Gastroenterology & Hepatology ·Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, (unknown), Takeshi Fukuda, Yoko Matsushita, Yoshiyuki Narahara, (unknown), (unknown), Katsuhisa Nakatsuka, Katsuhiko Iwakiri, Chiaki Kawamoto, Choitsu Sakamoto	3
16	Serum 25‐hydroxyvitamin D₃ levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load 2014 ·Hepatology Research ·Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, (unknown), Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Yoshiyuki Narahara, Katsuhiko Iwakiri, Katsuhisa Nakatsuka, Chiaki Kawamoto, Choitsu Sakamoto	9
17	Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study 2013 ·Hepatitis Monthly ·Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, (unknown), Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Hideko Kidokoro, Yoshiyuki Narahara, Katsuhisa Nakatsuka, Katsuhiko Iwakiri, Chiaki Kawamoto, Choitsu Sakamoto	12
18	An open‐label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin 2012 ·Journal of Viral Hepatitis ·Chisa Kondo, Masanori Atsukawa, Akihito Tsubota, Norio Itokawa, T. Fukuda, Yasushi Matsushita, Hideko Kidokoro, Takashi Kobayashi, Yoshiyuki Narahara, Katsuhisa Nakatsuka, Hideko Kanazawa, Choitsu Sakamoto	25
19	Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension 2012 ·Journal of Gastroenterology ·Yoko Matsushita, Yoshiyuki Narahara, Shunji Fujimori, Hidenori Kanazawa, Norio Itokawa, Takeshi Fukuda, Yōko Takahashi, Chisa Kondo, Hideko Kidokoro, Masanori Atsukawa, Katsuhisa Nakatsuka, Choitsu Sakamoto	12
20	A case of IgG4-related disease with rectal cancer 2011 ·Clinical Journal of Gastroenterology ·Norio Itokawa, Masanori Atsukawa, Takayoshi Nishino, Chisa Kondo, Takeshi Fukuda, Yoko Matsushita, Hideko Kidokoro, (unknown), Yoshiyuki Narahara, Shu Tanaka, Katsuhisa Nakatsuka, (unknown), Choitsu Sakamoto	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact